House Majority Leader Steve Scalise has a ‘very treatable’ blood cancer

House Majority Leader Steve Scalise has a ‘very treatable’ blood cancer


U.S. House Majority Leader Rep. Steve Scalise (R-La.) listens during a press conference following a House Republican Conference meeting at the U.S. Capitol Building in Washington, D.C., July 18, 2023.

Anna Moneymaker | Getty Images

House Majority Leader Steve Scalise said Tuesday that he has been diagnosed with multiple myeloma, which he called “a very treatable blood cancer.”

The Louisiana Republican underwent tests after “not feeling like myself this past week,” he said in a statement. “I have now begun treatment, which will continue for the next several months.”

Scalise, 57, said he intends to continue working as he receives treatment and will return to Washington, D.C., but did not say precisely when.

Congress is slated to return to the U.S. Capitol after Labor Day for a busy month.

This isn’t the first time Scalise has dealt with a major health scare.

In 2017, he was one of six people injured in a mass shooting in Alexandria, Virginia, during a team practice for the annual Congressional Baseball Game.

Scalise was shot in the hip and the bullet ruptured several organs. He underwent months of surgeries and blood transfusions on the way to recovery.



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More